Nanobiotix (NBTX) Non-Current Assets (2018 - 2025)

Nanobiotix (NBTX) recorded quarterly Non-Current Assets of $5.8 million in Q4 2025, down 2.5% quarter-over-quarter from $6.0 million in Q2 2025, and down 8.29% on a YoY basis from $6.4 million in Q4 2024.

Nanobiotix (NBTX) Non-Current Assets (2018 - 2025) Analysis & Trends

Nanobiotix's Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.8 million for Q4 2025.

  • In Q4 2025, Non-Current Assets fell 8.29% year-over-year to $5.8 million; the TTM figure through Dec 2025 stood at $5.8 million (down 8.29% YoY), while the FY2025 annual figure was $5.7 million, down 10.99% from the prior year.
  • Non-Current Assets was $5.8 million for Q4 2025 at Nanobiotix, down from $6.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $10.0 million in Q4 2021 to a low of $5.8 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $7.5 million across 5 years, with a median of $7.2 million in 2023.
  • The sharpest annual moves came in 2021 and 2022: Non-Current Assets dropped 4.85% in 2021, then declined 24.1% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $10.0 million in 2021, then slipped by 24.1% to $7.6 million in 2022, then decreased by 6.69% to $7.1 million in 2023, then fell by 9.88% to $6.4 million in 2024, then decreased by 8.29% to $5.8 million in 2025.
  • The last three Non-Current Assets figures came in at $5.8 million (Q4 2025), $6.0 million (Q2 2025), and $6.4 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 62,953.78
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 4.56 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 30.30 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 14.75 Bn
9 Abivax 90.15 Bn 90.15 Bn - 39.71 Mn
10 Nanobiotix 59.17 Mn -2.23 Mn - 5.83 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.83 Mn
Jun 30, 2025 5.98 Mn
Dec 31, 2024 6.36 Mn
Jun 30, 2024 6.70 Mn
Dec 31, 2023 7.06 Mn
Jun 30, 2023 7.38 Mn
Dec 31, 2022 7.56 Mn
Jun 30, 2022 8.29 Mn
Dec 31, 2021 9.96 Mn
Jun 30, 2021 9.69 Mn
Dec 31, 2020 10.47 Mn
Dec 31, 2019 11.16 Mn
Dec 31, 2018 4.05 Mn